BREAKING
AI Cuts Preclinical Drug Costs 70%
0
B
avg cost
0
yr+
typical timeline
0
%
clinical success
0
%
faster to target
0
%
better hit rates
0
%
raising AI budgets
AI Share of R&D Budgets Rising
2024
10
2027
16
Momentum Meets Real Limits
Promise
●
Lilly, Novartis, Pfizer adopt AI
●
Faster, cheaper preclinical work
Caution
●
No FDA-approved AI drug yet
●
Failure rates near 90% may persist
Healthcare AI Market Set to Surge
AI NEWS BLITZ
A TD Cowen survey finds AI is slashing the earliest stages of drug development.